
CellSight Diagnosis delivers rapid, AI-based leukemia diagnosis from microscopic images. It uses deep neural networks and image processing to distinguish immature leukemic blasts from normal cells. The platform targets medical labs and clinics, integrating with existing workflows. This approach aims to bridge diagnostic gaps and improve patient outcomes at scale.

CellSight Diagnosis delivers rapid, AI-based leukemia diagnosis from microscopic images. It uses deep neural networks and image processing to distinguish immature leukemic blasts from normal cells. The platform targets medical labs and clinics, integrating with existing workflows. This approach aims to bridge diagnostic gaps and improve patient outcomes at scale.